Cargando…

The cellular prion protein controls the mesenchymal-like molecular subtype and predicts disease outcome in colorectal cancer

BACKGROUND: Comprehensive transcriptomic analyses have shown that colorectal cancer (CRC) is heterogeneous and have led to the definition of molecular subtypes among which the stem-cell, mesenchymal-like group is associated with poor prognosis. The molecular pathways orchestrating the emergence of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Le Corre, Delphine, Ghazi, Alexandre, Balogoun, Ralyath, Pilati, Camilla, Aparicio, Thomas, Martin-Lannerée, Séverine, Marisa, Laetitia, Djouadi, Fatima, Poindessous, Virginie, Crozet, Carole, Emile, Jean-François, Mulot, Claire, Le Malicot, Karine, Boige, Valérie, Blons, Hélène, de Reynies, Aurélien, Taieb, Julien, Ghiringhelli, François, Bennouna, Jaafar, Launay, Jean-Marie, Laurent-Puig, Pierre, Mouillet-Richard, Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710984/ https://www.ncbi.nlm.nih.gov/pubmed/31377347 http://dx.doi.org/10.1016/j.ebiom.2019.07.036

Ejemplares similares

Prognostic value of the PrP(C)-ILK-IDO1 axis in the mesenchymal colorectal cancer subtype
por: Ghazi, Alexandre, et al.
Publicado: (2021)

A proof of concept for targeting the PrP(C) - Amyloid β peptide interaction in basal prostate cancer and mesenchymal colon cancer
por: Mouillet-Richard, Sophie, et al.
Publicado: (2022)

Predictive value of vascular endothelial growth factor polymorphisms for maintenance bevacizumab efficacy in metastatic colorectal cancer: an ancillary study of the PRODIGE 9 phase III trial
por: de Rauglaudre, Bernadette, et al.
Publicado: (2022)

Intratumor CMS Heterogeneity Impacts Patient Prognosis in Localized Colon Cancer
por: Marisa, Laetitia, et al.
Publicado: (2021)

Predictive factors for early progression during induction chemotherapy and chemotherapy-free interval: analysis from PRODIGE 9 trial
por: Aparicio, Thomas, et al.
Publicado: (2020)

Hijacking PrP(c)-dependent signal transduction: when prions impair Aβ clearance
por: Hernandez-Rapp, Julia, et al.
Publicado: (2014)

The cellular prion protein is a stress protein secreted by renal tubular cells and a urinary marker of kidney injury
por: Bignon, Yohan, et al.
Publicado: (2020)

PrP(C) from stem cells to cancer
por: Martin-Lannerée, Séverine, et al.
Publicado: (2014)

A PrP(C)-caveolin-Lyn complex negatively controls neuronal GSK3β and serotonin 1B receptor
por: Hernandez-Rapp, Julia, et al.
Publicado: (2014)

Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study
por: Reichling, Cynthia, et al.
Publicado: (2020)

STK11/LKB1 Modulation of the Immune Response in Lung Cancer: From Biology to Therapeutic Impact
por: Pons-Tostivint, Elvire, et al.
Publicado: (2021)

Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study
por: Pernot, Simon, et al.
Publicado: (2018)

To develop with or without the prion protein
por: Halliez, Sophie, et al.
Publicado: (2014)

Homozygous Co-Deletion of Type I Interferons and CDKN2A Genes in Thoracic Cancers: Potential Consequences for Therapy
por: Grard, Marion, et al.
Publicado: (2021)

ERCC1, XRCC1 and GSTP1 Single Nucleotide Polymorphisms and Survival of Patients with Colon Cancer Receiving Oxaliplatin-Based Adjuvant Chemotherapy
por: Zaanan, Aziz, et al.
Publicado: (2014)

Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer
por: Grancher, Adrien, et al.
Publicado: (2022)

Downregulation of mitochondrial complex I induces ROS production in colorectal cancer subtypes that differently controls migration
por: Bastin, Jean, et al.
Publicado: (2023)

Impact of G-CSF Prophylaxis on Chemotherapy Dose-Intensity, Link Between Dose-Intensity and Survival in Patients with Metastatic Pancreatic Adenocarcinoma
por: Canton, Clémence, et al.
Publicado: (2022)

Characterization of Plasma Cell-Free DNA Integrity Using Droplet-Based Digital PCR: Toward the Development of Circulating Tumor DNA-Dedicated Assays
por: Poulet, Geoffroy, et al.
Publicado: (2021)

Baseline Splenic Volume as a Prognostic Biomarker of FOLFIRI Efficacy and a Surrogate Marker of MDSC Accumulation in Metastatic Colorectal Carcinoma
por: Niogret, Julie, et al.
Publicado: (2020)

Is There a Place for Immunotherapy for Metastatic Microsatellite Stable Colorectal Cancer?
por: Ghiringhelli, François, et al.
Publicado: (2019)

Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial
por: Taïeb, Julien, et al.
Publicado: (2023)

Prion protein localizes at the ciliary base during neural and cardiovascular development, and its depletion affects α-tubulin post-translational modifications
por: Halliez, Sophie, et al.
Publicado: (2015)

DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study
por: Kim, Stefano, et al.
Publicado: (2023)

Performance and Cost Efficiency of KRAS Mutation Testing for Metastatic Colorectal Cancer in Routine Diagnosis: The MOKAECM Study, a Nationwide Experience
por: Blons, Hélène, et al.
Publicado: (2013)

Stilbenes and resveratrol metabolites improve mitochondrial fatty acid oxidation defects in human fibroblasts
por: Aires, Virginie, et al.
Publicado: (2014)

Neoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial – the PRODIGE 22 - ECKINOXE trial
por: Karoui, Mehdi, et al.
Publicado: (2015)

Osimertinib for Front-Line Treatment of Locally Advanced or Metastatic EGFR-Mutant NSCLC Patients: Efficacy, Acquired Resistance and Perspectives for Subsequent Treatments
por: Denis, Marc G, et al.
Publicado: (2020)

Treatments for Non-Small-Cell Lung Cancer: The Multiple Options for Precision Medicine
por: Pons-Tostivint, Elvire, et al.
Publicado: (2022)

Targeting BRAF and RAS in Colorectal Cancer
por: Bellio, Helene, et al.
Publicado: (2021)

Impact of time-varying cumulative bevacizumab exposures on survival: re-analysis of data from randomized clinical trial in patients with metastatic colo-rectal cancer
por: Guilloteau, Adrien, et al.
Publicado: (2021)

Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial
por: Boige, Valérie, et al.
Publicado: (2023)

First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial
por: Thibaudin, Marion, et al.
Publicado: (2023)

The Cellular Prion Protein and the Hallmarks of Cancer
por: Mouillet-Richard, Sophie, et al.
Publicado: (2021)

RNA Network Interactions During Differentiation of Human Trophoblasts
por: Chu, Tianjiao, et al.
Publicado: (2021)

Confidence as a Common Currency between Vision and Audition
por: de Gardelle, Vincent, et al.
Publicado: (2016)

Vaccination against HPV: Easier said than done?
por: Stoeklé, Henri-Corto, et al.
Publicado: (2023)

Raphe-mediated signals control the hippocampal response to SRI antidepressants via miR-16
por: Launay, J M, et al.
Publicado: (2011)

Immunogenic Cell Death and Elimination of Immunosuppressive Cells: A Double-Edged Sword of Chemotherapy
por: Fumet, Jean-David, et al.
Publicado: (2020)

MAPK signaling regulates the efficacy of chemoimmunotherapy
por: Ghiringhelli, François
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_afjn7ducfeotgavpb9pl73n6uh